Latest 10-Q quarterly reports

Washington Trust Bancorp reported a modest increase in net income for Q1 2026, driven by higher net interest income and growth in wealth management, despite a rise in provision for credit losses.

Avient Corporation announced a significant turnaround in its first quarter 2026 financial results, reporting a net income of $55.8 million, a substantial improvement from a loss in the prior year.

Camden National Corporation reported a significant increase in net income for the first quarter of 2026, driven by strong net interest income and improved operational efficiencies.

Lamar Media Corp. has filed a supplemental indenture dated January 21, 2026, adding INDIANA LOGOS, LLC as a new guarantor for its 3.625% Senior Notes due 2031.

Watts Water Technologies reports a significant 21.4% increase in net sales for Q1 2026, driven by strong organic growth and strategic acquisitions.

Tronox Holdings PLC reported a net loss of $104 million for Q1 2026, with net sales increasing 3% year-over-year to $760 million.

Deluxe Corporation reported a Q1 2026 with total revenue slightly increasing to $538.1 million, while net income saw a significant jump to $35.8 million, driven by cost management and growth in payments and data segments.

Park-Ohio Holdings Corp. reports a 3.8% increase in net sales for Q1 2026, reaching $421.0 million, driven by higher customer demand across its segments, though net income attributable to common shareholders saw a slight decrease.

Ormat Technologies reports a significant 75.8% increase in total revenues for Q1 2026, driven by a substantial surge in its Product segment, alongside growth in Energy Storage.

Whirlpool Corporation reported a net loss for the first quarter of 2026, impacted by lower sales volume and inventory reduction costs, though it raised capital through stock and preferred stock offerings.

Clearfield, Inc. announced its financial results for the second quarter of fiscal year 2026, reporting a decrease in net sales and a net loss.

Spectrum Brands Holdings, Inc. reported a significant increase in net income for the second quarter of fiscal year 2026, driven by higher sales and improved profitability across its segments.

Gibraltar Industries reported a net loss of $67.5 million for Q1 2026, impacted by significant acquisition costs and a substantial loss from discontinued operations, despite a revenue increase driven by recent acquisitions.

EPR Properties reported a 3.6% increase in total revenue for Q1 2026 compared to the prior year, though net income available to common shareholders saw a 5.1% decrease.

Aardvark Therapeutics announced a voluntary pause in its clinical trials for ARD-101 and ARD-201 due to reversible cardiac observations in a healthy volunteer study, impacting development timelines and future guidance.

Conectisys Corporation files its Q1 2026 10-Q, reporting continued operational inactivity and a net loss, while pursuing a merger strategy.

BlackRock TCP Capital Corp. reported a net decrease in net assets of $16.3 million for Q1 2026, primarily driven by higher net realized and unrealized losses and lower net investment income compared to the prior year.

Iovance Biotherapeutics Inc. reported a 45% increase in total revenue for the first quarter of 2026, driven by strong Amtagvi and Proleukin sales, while net loss narrowed.

N-able, Inc. announced its first quarter 2026 financial results, showing a 13.1% increase in total revenue to $133.7 million and a reduced net loss of $0.6 million.

NCR Atleos Corporation announced its first quarter 2026 financial results, showing a 7% increase in total revenue to $1.04 billion, driven by growth in its Self-Service Banking segment, while navigating the ongoing merger process with The Brinks Company.

Delcath Systems, Inc. reported its first quarter 2026 financial results, showing a significant increase in revenue driven by its HEPZATO KIT product.

Praxis Precision Medicines reports increased R&D spending and net loss in Q1 2026, but maintains a strong cash position and advances multiple drug candidates.

MBX Biosciences reports a net loss of $23.5 million for Q1 2026, with decreased R&D expenses but higher G&A costs, while maintaining a substantial cash reserve of $440 million.

Rave Restaurant Group reports increased revenues and net income for the third quarter ended March 29, 2026, driven by strong performance in its Pizza Inn segment.

Lipocine Inc. reported Q1 2026 results, highlighting a significant setback in its LPCN 1154 Phase 3 trial for postpartum depression, while continuing to advance other pipeline candidates and manage existing licensing agreements.

Theravance Biopharma announced first-quarter 2026 financial results, reporting a net loss of $4.9 million, and confirmed the wind-down of its ampreloxetine program following unsuccessful Phase 3 trial results.

Loar Holdings reported a significant increase in net sales for Q1 2026, driven by recent acquisitions, though net income saw a decrease due to higher interest and amortization expenses.

Universal Technical Institute (UTI) reported a 6.7% revenue increase for the second quarter of fiscal year 2026, driven by higher student enrollment and new program launches, despite increased strategic growth expenses.

Privia Health Group, Inc. has amended its credit agreement to increase the revolving credit commitment and extend the maturity date.

SM Energy Company reported a net loss for the first quarter of 2026, largely due to significant derivative losses, while integrating the recently completed merger with Civitas Resources.